Eupraxia Pharmaceuticals Inc.
EPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $107,560 | $94,306 | $77,040 | $53,111 |
| - Cash | $33,101 | $19,342 | $24,728 | $20,892 |
| + Debt | $72 | $10,452 | $12,166 | $9,991 |
| Enterprise Value | $74,530 | $85,416 | $64,479 | $42,210 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$35,905 | -$27,604 | -$17,860 | -$17,224 |
| % Margin | – | – | – | – |
| Net Income | -$36,675 | -$28,221 | -$18,490 | -$18,031 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.76 | -1.17 | -0.96 | -1.61 |
| % Growth | 35% | -21.9% | 40.4% | – |
| Operating Cash Flow | -$29,994 | -$20,749 | -$14,395 | -$11,576 |
| Capital Expenditures | -$104 | -$73 | -$236 | -$341 |
| Free Cash Flow | -$30,099 | -$20,822 | -$14,631 | -$11,917 |